Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis/ Eczema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04626297
What this trial is testing

Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 254
Not applicableEnded earlyNCT05443490
What this trial is testing

Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in Children

Who this might be right for
Atopic Dermatitis
Bionou Research, S.L. 4
Testing effectiveness (Phase 2)Study completedNCT03160248
What this trial is testing

An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema

Who this might be right for
Nummular EczemaEczemaDermatitis Eczema+1 more
Technical University of Munich 31
Testing effectiveness (Phase 2)Study completedNCT04800315
What this trial is testing

Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, AtopicEczema
Celgene 221
Early research (Phase 1)Study completedNCT02103725
What this trial is testing

A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 30
Large-scale testing (Phase 3)Study completedNCT06181435
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

Who this might be right for
Dermatitis Atopic
Sanofi 589
Post-approval studies (Phase 4)Ended earlyNCT02317276
What this trial is testing

Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal

Who this might be right for
Dermatitis, Atopic
University of California, San Francisco 11
Not applicableWithdrawnNCT01936194
What this trial is testing

The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Mead Johnson Nutrition
Large-scale testing (Phase 3)Looking for participantsNCT07355075
What this trial is testing

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

Who this might be right for
Eczema Atopic DermatitisEczemaAtopic Dermatitis
Turn Therapeutics 190
Not applicableStudy completedNCT05140239
What this trial is testing

Effects of Abrocitinib Treatment on Skin Barrier Function

Who this might be right for
Atopic Dermatitis
Prof. Dr. Stephan Weidinger 20
Not applicableLooking for participantsNCT07347743
What this trial is testing

Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns.

Who this might be right for
ColicHealthy InfantsEczema Atopic Dermatitis
Universitair Ziekenhuis Brussel 768
Large-scale testing (Phase 3)WithdrawnNCT05233410
What this trial is testing

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

Who this might be right for
Chronic Hand Eczema (CHE)
Incyte Corporation
Post-approval studies (Phase 4)Study completedNCT05602207
What this trial is testing

Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab

Who this might be right for
Atopic Dermatitis
Innovaderm Research Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07399067
What this trial is testing

A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT02780167
What this trial is testing

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 269
Testing effectiveness (Phase 2)Study completedNCT04893707
What this trial is testing

The Study of CM310 in Patients With Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Keymed Biosciences Co.Ltd 127
Early research (Phase 1)Study completedNCT04975438
What this trial is testing

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 34
Not applicableStudy completedNCT03770858
What this trial is testing

Wearable Skin Sensors to Assess Nocturnal Scratch Behavior

Who this might be right for
Atopic Dermatitis
Northwestern University 23
Early research (Phase 1)Study completedNCT05383378
What this trial is testing

A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
selectION Therapeutics GmbH 36
Early research (Phase 1)Study completedNCT06193434
What this trial is testing

A First In Human (FIH) Study of IBI356 in Healthy Participants and in Atopic Dermatitis Patients

Who this might be right for
Healthy ParticipantsAtopic Dermatitis Patients
Innovent Biologics (Suzhou) Co. Ltd. 99
Next Page